(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...
Stats | |
---|---|
本日の出来高 | 74 966.00 |
平均出来高 | 49 733.00 |
時価総額 | 16.53B |
EPS | $0 ( 2024-03-19 ) |
次の収益日 | ( $0 ) 2024-05-14 |
Last Dividend | $0.247 ( 2023-05-18 ) |
Next Dividend | $0 ( N/A ) |
P/E | 43.16 |
ATR14 | $0.0150 (0.20%) |
ボリューム 相関
Fresenius SE & Co. KGaA 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Fresenius SE & Co. KGaA 相関 - 通貨/商品
Fresenius SE & Co. KGaA 財務諸表
Annual | 2023 |
収益: | $22.30B |
総利益: | $5.06B (22.68 %) |
EPS: | $-1.050 |
FY | 2023 |
収益: | $22.30B |
総利益: | $5.06B (22.68 %) |
EPS: | $-1.050 |
FY | 2022 |
収益: | $40.84B |
総利益: | $10.73B (26.26 %) |
EPS: | $3.77 |
FY | 2021 |
収益: | $37.52B |
総利益: | $10.31B (27.48 %) |
EPS: | $0.815 |
Financial Reports:
No articles found.
Fresenius SE & Co. KGaA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.247 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.119 | 2013-05-15 |
Last Dividend | $0.247 | 2023-05-18 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-30 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $2.15 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.98 | -- |
Div. Sustainability Score | 7.07 | |
Div.Growth Potential Score | 2.07 | |
Div. Directional Score | 4.57 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RNMBY | Ex Dividend Knight | 2023-05-10 | Annually | 0 | 0.00% | |
FFDF | Ex Dividend Knight | 2023-08-01 | Quarterly | 0 | 0.00% | |
WBHC | Ex Dividend Junior | 2023-06-29 | Sporadic | 0 | 0.00% | |
LYBC | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
CLLNY | Ex Dividend Junior | 2023-06-16 | Semi-Annually | 0 | 0.00% | |
SLVYY | Ex Dividend Knight | 2023-05-15 | Semi-Annually | 0 | 0.00% | |
HALMY | Ex Dividend Knight | 2023-07-14 | Semi-Annually | 0 | 0.00% | |
AMADY | Ex Dividend Knight | 2023-07-11 | Annually | 0 | 0.00% | |
NDBKY | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% | |
CRZBY | Ex Dividend Junior | 2023-06-01 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0150 | 1.500 | -0.300 | -0.450 | [0 - 0.5] |
returnOnAssetsTTM | -0.0105 | 1.200 | -0.351 | -0.421 | [0 - 0.3] |
returnOnEquityTTM | -0.0240 | 1.500 | -1.377 | -2.07 | [0.1 - 1] |
payoutRatioTTM | -2.58 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.342 | 0.800 | 8.29 | 6.63 | [1 - 3] |
quickRatioTTM | 0.922 | 0.800 | 9.29 | 7.43 | [0.8 - 2.5] |
cashRatioTTM | 0.275 | 1.500 | 9.59 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.310 | -1.500 | 4.83 | -7.25 | [0 - 0.6] |
interestCoverageTTM | 2.67 | 1.000 | -0.121 | -0.121 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.91 | 2.00 | 7.36 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.48 | 2.00 | 7.26 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.739 | -1.500 | 7.04 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.233 | 1.000 | 9.45 | 9.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0585 | 1.000 | -0.829 | -0.829 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.317 | 1.000 | 9.35 | 9.35 | [0.2 - 2] |
assetTurnoverTTM | 0.702 | 0.800 | 8.65 | 6.92 | [0.5 - 2] |
Total Score | 7.07 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -8.10 | 1.000 | -0.919 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0240 | 2.50 | -0.885 | -2.07 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.48 | 2.00 | 8.17 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.60 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.91 | 2.00 | 7.36 | 10.00 | [0 - 30] |
payoutRatioTTM | -2.58 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | -0.0174 | 1.500 | -3.45 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 2.07 |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。